Kailash N Pandey Selected Research

atrial natriuretic factor receptor A

1/2020	Depletion of cyclic-GMP levels and inhibition of cGMP-dependent protein kinase activate p21Cip1 /p27Kip1 pathways and lead to renal fibrosis and dysfunction.
7/2015	Endocytosis and Trafficking of Natriuretic Peptide Receptor-A: Potential Role of Short Sequence Motifs.
12/2010	Targeted disruption of guanylyl cyclase-A/natriuretic peptide receptor-A gene provokes renal fibrosis and remodeling in null mutant mice: role of proinflammatory cytokines.
10/2007	Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy.
7/2007	Guanylyl cyclase/natriuretic peptide receptor-A gene disruption causes increased adrenal angiotensin II and aldosterone levels.
5/2005	Involvement of the NF-kappa B/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A.
2/2005	Reduced cGMP signaling activates NF-kappaB in hypertrophied hearts of mice lacking natriuretic peptide receptor-A.
10/2003	Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kailash N Pandey Research Topics

Disease

8	Fibrosis (Cirrhosis) 01/2020 - 02/2005
7	Heart Failure 01/2021 - 02/2005
7	Hypertension (High Blood Pressure) 01/2021 - 07/2008
6	Cardiomegaly (Heart Hypertrophy) 12/2010 - 02/2005
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 06/2011
3	Heart Diseases (Heart Disease) 01/2021 - 10/2003
2	Hypertrophy 01/2020 - 02/2010
1	Kidney Diseases (Kidney Disease) 08/2019
1	Inflammation (Inflammations) 01/2017
1	Body Weight (Weight, Body) 01/2016
1	Stroke (Strokes) 08/2011
1	Necrosis 02/2010

Drug/Important Bio-Agent (IBA)

8	atrial natriuretic factor receptor AIBA 01/2020 - 10/2003
5	CytokinesIBA 01/2019 - 04/2007
4	Natriuretic PeptidesIBA 01/2021 - 07/2008
4	Guanylate Cyclase (Guanylyl Cyclase)IBA 01/2020 - 05/2005
3	Atrial Natriuretic Factor (ANF)IBA 01/2021 - 08/2011
3	NF-kappa B (NF-kB)IBA 01/2016 - 02/2005
2	Hormones (Hormone)IBA 01/2021 - 07/2015
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2017 - 01/2016
2	Butyric Acid (Butanoic Acid)IBA 01/2017 - 01/2016
2	Matrix Metalloproteinases (MMPs)IBA 01/2016 - 05/2005
1	DiureticsIBA 01/2021
1	Vasodilator Agents (Vasodilators)IBA 01/2021
1	CyclinsIBA 01/2020
1	Cyclic GMPIBA 01/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020
1	A 71915IBA 01/2020
1	Cell Cycle ProteinsIBA 01/2020
1	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 01/2020
1	Sirolimus (Rapamycin)FDA Link 01/2019
1	Histone Deacetylase InhibitorsIBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2016
1	SodiumIBA 01/2016
1	Ventricular MyosinsIBA 01/2016
1	GuanosineIBA 07/2015
1	andrographolideIBA 04/2012
1	pyrrolidine dithiocarbamic acidIBA 04/2012
1	Etanercept (Enbrel)FDA Link 04/2012
1	Proteins (Proteins, Gene)FDA Link 06/2011
1	Captopril (Capoten)FDA LinkGeneric 12/2010
1	Losartan (Cozaar)FDA LinkGeneric 12/2010
1	Interleukin-6 (Interleukin 6)IBA 02/2010
1	CollagenIBA 05/2005
1	Collagen Type I (Type I Collagen)IBA 05/2005